{"title":"13. PET and CT Correlation","authors":"Hoffman RB","doi":"10.1016/S1095-0397(00)00079-0","DOIUrl":null,"url":null,"abstract":"<div><p><strong>Purpose:</strong> The purpose of this investigation is to compare and explain discordant findings on high quality PET and CT where no corresponding CT abnormality is seen despite a significant appearing PET abnormality.</p><p><strong>Methods:</strong> The methods involved the review of forty sequential oncologic cases. State-of-the-art helical post contrast CT scans and state-of the-art attenuated corrected and uncorrected PET images were examined. Discordant findings were classified as: Type A Obvious PET abnormalities fail to reveal CT anatomic abnormalities. Type B CT anatomic abnormalities show no PET abnormalities (usually benign disease). Only Type A discordance was evaluated and repeat CT scans were obtained if more than two weeks separated the exams.</p><p><strong>Results:</strong> The results showed that there were four cases of Type A discordance. Case I showed a large PET abnormality with a negative CT. Repeat CT was again negative. The suspicion of a mis-registration artifact on PET due to motion was confirmed. Cases II, III, & IV had prominent PET abnormalities with normal CT scans within two to six weeks preceding the PET. Repeat CTs showed remarkable new findings corresponding exactly with the PET abnormalities.</p><p><strong>Conclusion:</strong> In conclusion, when a conspicuous hypermetabolic focus has no corresponding CT anatomic structure on a high quality CT exam, extra evaluation is in order. Aside from technical artifacts, a relatively short time delay between CT and PET may account for development of new findings on CT in the face of aggressive disease.</p></div>","PeriodicalId":80267,"journal":{"name":"Clinical positron imaging : official journal of the Institute for Clinical P.E.T","volume":"3 4","pages":"Page 167"},"PeriodicalIF":0.0000,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1095-0397(00)00079-0","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical positron imaging : official journal of the Institute for Clinical P.E.T","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1095039700000790","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Purpose: The purpose of this investigation is to compare and explain discordant findings on high quality PET and CT where no corresponding CT abnormality is seen despite a significant appearing PET abnormality.
Methods: The methods involved the review of forty sequential oncologic cases. State-of-the-art helical post contrast CT scans and state-of the-art attenuated corrected and uncorrected PET images were examined. Discordant findings were classified as: Type A Obvious PET abnormalities fail to reveal CT anatomic abnormalities. Type B CT anatomic abnormalities show no PET abnormalities (usually benign disease). Only Type A discordance was evaluated and repeat CT scans were obtained if more than two weeks separated the exams.
Results: The results showed that there were four cases of Type A discordance. Case I showed a large PET abnormality with a negative CT. Repeat CT was again negative. The suspicion of a mis-registration artifact on PET due to motion was confirmed. Cases II, III, & IV had prominent PET abnormalities with normal CT scans within two to six weeks preceding the PET. Repeat CTs showed remarkable new findings corresponding exactly with the PET abnormalities.
Conclusion: In conclusion, when a conspicuous hypermetabolic focus has no corresponding CT anatomic structure on a high quality CT exam, extra evaluation is in order. Aside from technical artifacts, a relatively short time delay between CT and PET may account for development of new findings on CT in the face of aggressive disease.